Catalyst Wire Dossier Catalyst Wire Dossier

BI 1021958

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for BI 1021958, covering 2013-05-16 to 2014-12-24. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Repeated Doses of BI 1060469 and BI 1021958 on Glomerular Filtration Rate (GFR) in Healthy Volunteers [Phase 1]

See pricing